Discrepancies between metabolic activity and DNA content as tool to assess cell proliferation in cancer research

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 4, 2010, Pages 1003-1013

  Quent, Verena M C ^a   Loessner, Daniela ^a   Friis, Thor ^a   Reichert, Johannes C ^a   Hutmacher, Dietmar W ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Cancer cells; Cell proliferation; DNA content; Metabolic activity; Proliferation assay

Indexed keywords

DNA; OXAZINE DERIVATIVE; RESAZURIN; XANTHENE DERIVATIVE;

AGED; ARTICLE; BIOASSAY; CELL PROLIFERATION; FEMALE; HUMAN; MEDICAL RESEARCH; METABOLISM; METHODOLOGY; NEOPLASM; PATHOLOGY; PUBLICATION; TIME; TUMOR CELL LINE;

AGED; BIOLOGICAL ASSAY; BIOMEDICAL RESEARCH; CELL LINE, TUMOR; CELL PROLIFERATION; DNA, NEOPLASM; FEMALE; HUMANS; NEOPLASMS; OXAZINES; PUBLICATIONS; TIME FACTORS; XANTHENES;

EID: 77953953888     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01013.x     Document Type: Article

References (21)

1. Jones LJ, Gray M, Yue ST. Sensitive determination of cell number using the CyQUANT cell proliferation assay. J Immunol Methods. 2001, 254:85-98.
2. Pierre RV. Peripheral blood film review. The demise of the eyecount leukocyte differential. Clin Lab Med. 2002, 22:279-97.
3. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983, 65:55-63.
4. Berridge MV, Herst PM, Tan AS. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. 2005, 127-52. Biotechnology Annual Review. Elsevier.
5. O'Brien J, Wilson I, Orton T. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem. 2000, 267:5421-6.
6. Al-Nasiry S, Geusens N, Hanssens M. The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum Reprod. 2007, 22:1304-9.
7. Blaheta RA, Kronenberger B, Woitaschek D. Development of an ultrasensitive in vitro assay to monitor growth of primary cell cultures with reduced mitotic activity. J Immunol Methods. 1998, 211:159-69.
8. Ng KW, Leong DT, Hutmacher DW. The challenge to measure cell proliferation in two and three dimensions. Tissue Eng. 2005, 11:182-91.
9. Lopez-Barcons LA. Serially heterotransplanted human prostate tumors as an experimental model. J Cell Mol Med. 2009, 10.1111/j.1582-4934.2009.00957.x
10. Rattan R, Giri S, Hartmann L. Metformin attenuates ovarian cancer cell growth in an AMP- kinase dispensable manner. J Cell Mol Med. 2009, 10.1111/j.1582-4934.2009.00954.x
11. Mobus V, Gerharz CD, Press U. Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines. Int J Cancer. 1992, 52:76-84.
12. Fogh J, Fogh JM, Orfeo T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst. 1977, 59:221-6.
13. Sarugaser R, Lickorish D, Baksh D. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells. 2005, 23:220-9.
14. Hutmacher DW, Horch RE, Loessner D. Translating tissue engineering technology platforms into cancer research. J Cell Mol Med. 2009, 13:1417-27.
15. Mimeault M, Batra SK. Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies. J Cell Mol Med 2009
16. Slater TF, Sawyer B, Straeuli U. Studies on succinate-tetrazolium reductase systems. Iii. Points of coupling of four different tetrazolium salts. Biochim Biophys Acta. 1963, 77:383-93.
17. Berridge MV, Tan AS, McCoy KD. The biochemical and cellular basis of cell proliferation assays that use tetrazolium salts. Biochemica 1996, 14-9.
18. Nociari MM, Shalev A, Benias P. A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. J Immunol Methods. 1998, 213:157-67.
19. Fields RD, Lancaster MV. Dual-attribute continuous monitoring of cell proliferation/cytotoxicity. Am Biotechnol Lab. 1993, 11:48-50.
20. Zalata AA, Lammertijn N, Christophe A. The correlates and alleged biochemical background of the resazurin reduction test in semen. Int J Androl. 1998, 21:289-94.
21. Hamid R, Rotshteyn Y, Rabadi L. Comparison of alamar blue and MTT assays for high through-put screening. Toxicol In Vitro. 2004, 18:703-10.